Elanco acquires Boehringer Ingelheim Vetmedica’s US feline, canine & rabies vaccines portfolio
Elanco US Inc., a subsidiary of Eli Lilly and Company, has completed the acquisition of Boehringer Ingelheim Vetmedica, Inc’s (BIVI) US feline,... Read More